As of Feb 23
| +8.04 / +2.55%|
The 25 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 440.00, with a high estimate of 568.00 and a low estimate of 387.00. The median estimate represents a +35.86% increase from the last price of 323.86.
The current consensus among 29 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.